Publications by authors named "James Del Rosso"

Claim this Profile
T
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials.
Linda Stein Gold, James Del Rosso, Benjamin D Ehst, Matthew J Zirwas, Lawrence J Green

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
Kim A Papp, James Q Del Rosso, Mark G Lebwohl, Melinda J Gooderham, Adelaide A Hebert

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring New Dimensions in Longitudinal Rosacea Management.
Martin Schaller, Belinda Welsh, Giuseppe Micali, Jerry Tan, James Del Rosso

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.
Andrew F Alexis, Michael Bukhalo, Fran E Cook-Bolden, James Q Del Rosso, Zoe D Draelos

Am J Clin Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis.
Jonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, Gil Yosipovitch, Peter Lio, James Del Rosso

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.
Diego Ruiz Dasilva, Alondra Soto-González, Nicholas K Mollanazar, Somto Ndubisi, Naiem Issa, James Del Rosso

J Clin Aesthet Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies.
David Pariser, Dee Anna Glaser, James Del Rosso, Neal Bhatia, Deirdre Hooper

J Am Acad Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Insights: What Makes Some PDE4 Inhibitors More Effective in Inflammatory Dermatoses.
Naiem T Issa, Jimin Wang, Ailish Hanly, Minh Ho, Sabine Obagi, James Q Del Rosso

J Clin Aesthet Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can We Successfully Adapt to Changes in Direction and Support for Acne?
James Q Del Rosso

Cutis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials.
Neal Bhatia, James Del Rosso, Linda Stein Gold, Edward Lain, Zoe Diana Draelos

JAMA Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series.
Ana B W Greenberg, Mona Shahriari, Michael C Cameron, Michael Payette, Diego Ruiz Dasilva, James Q Del Rosso

J Clin Aesthet Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinician's Guide to Dupilumab-related Ocular Surface Disease.
Sandi Assaf, Peter Lio, James Q Del Rosso

J Clin Aesthet Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy.
Jonathan I Silverberg, Thomas Bieber, Amy S Paller, Lisa Beck, Masahiro Kamata, James Del Rosso

Dermatol Ther (Heidelb)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Glucagon-like Peptide-1 in Dermatology.
Willmar Patino, Amanda Thomas, Sanjana Jain, James Q Del Rosso, Naiem T Issa

J Clin Aesthet Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in .
Mahmoud Ghannoum, Ahmed Gamal, Ahmed Kadry, James Q Del Rosso, Linda Stein Gold

Clin Cosmet Investig Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin 101: Understanding the Fundamentals of Skin Barrier Physiology-Why is This Important for Clinicians?
James Q Del Rosso, Leon Kircik

J Clin Aesthet Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Efficacy of Atopic Dermatitis Systemic Therapeutics After Discontinuation Part I: Biologics.
Naiem T Issa, Rama Abdin, Kabir Al-Tariq, Dana Jaalouk, Michael Kaiser, James Del Rosso

J Clin Aesthet Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Reynolds et al's "Guidelines of care for the management of acne vulgaris".
James Q Del Rosso, Andrea Zaenglein, Valerie Callender, Bethanee Schlosser, Emmy Graber

J Am Acad Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents.
Lawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, Hilary Baldwin, Neal Bhatia, James Q Del Rosso

J Drugs Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitiligo Exchange: An Expert Panel Discussion of Two Clinical Cases.
James Del Rosso, Iltefat Hamzavi, Pearl Grimes

J Clin Aesthet Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
Jonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch

Dermatol Ther (Heidelb)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FORWARD Psoriasis Registry: Patient-Reported Outcomes in a Novel Psoriasis Registry and Comparison of Traditional, Dermatologist-Led Enrollment With Web-Based Patient Enrollment.
William B Song, Kaleb Michaud, Sarah L Lonowski, Mark Kaufmann, Ryan Pearson, James Q Del Rosso

J Psoriasis Psoriatic Arthritis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 2.6% Benzoyl Peroxide AV Cleanser Specifically Designed for Sensitive Skin Offers Good Efficacy and Tolerability.
James Q Del Rosso, Thu Q Nguyen, Christine Emesiani, Matthew Meckfessel

J Drugs Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clindamycin: A Comprehensive Status Report with Emphasis on Use in Dermatology.
James Q Del Rosso, Maria K Armillei, Ivan B Lomakin, Ayman Grada, Christopher G Bunick

J Clin Aesthet Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzoyl Peroxide, Benzene, and Lots of Unanswered Questions: Where Are We Now?
James Q Del Rosso

Cutis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis